GRIM-19 Ameliorates Multiple Sclerosis in a Mouse Model of Experimental Autoimmune Encephalomyelitis with Reciprocal Regulation of IFNγ/Th1 and IL-17A/Th17 Cells
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The protein encoded by the Gene Associated with Retinoid-Interferon-Induced Mortality-19 (GRIM-19) is located in the mitochondrial inner membrane and is homologous to the NADH dehydrogenase 1-alpha subcomplex subunit 13 of the electron transport chain. Multiple sclerosis (MS) is a demyelinating disease that damages the brain and spinal cord. Although both the cause and mechanism of MS progression remain unclear, it is accepted that an immune disorder is involved. We explored whether GRIM-19 ameliorated MS by increasing the levels of inflammatory cytokines and immune cells; we used a mouse model of experimental autoimmune encephalomyelitis (EAE) to this end. Six-to-eight-week-old male C57BL/6, IFNγ-knockout (KO), and GRIM-19 transgenic mice were used; EAE was induced in all strains. A GRIM-19 overexpression vector (GRIM19 OVN) was electrophoretically injected intravenously. The levels of Th1 and Th17 cells were measured via flow cytometry, immunofluorescence, and immunohistochemical analysis. IL-17A and IFNγ expression levels were assessed via ELISA and quantitative PCR. IL-17A expression decreased and IFNγ expression increased in EAE mice that received injections of the GRIM19 OVN. GRIM-19 transgenic mice expressed more IFNγ than did wild-type mice; this inhibited EAE development. However, the effect of GRIM-19 overexpression on the EAE of IFNγ-KO mice did not differ from that of the empty vector. GRIM-19 expression was therapeutic for EAE mice, elevating the IFNγ level. GRIM-19 regulated the Th17/Treg cell balance.
Abstract
The protein encoded by the Gene Associated with Retinoid-Interferon-Induced Mortality-19 (GRIM-19) is located in the mitochondrial inner membrane and is homologous to the NADH dehydrogenase 1-alpha subcomplex subunit 13 of the electron transport chain. Multiple sclerosis (MS) is a demyelinating disease that damages the brain and spinal cord. Although both the cause and mechanism of MS progression remain unclear, it is accepted that an immune disorder is involved. We explored whether GRIM-19 ameliorated MS by increasing the levels of inflammatory cytokines and immune cells; we used a mouse model of experimental autoimmune encephalomyelitis (EAE) to this end. Six-to-eight-week-old male C57BL/6, IFNγ-knockout (KO), and GRIM-19 transgenic mice were used; EAE was induced in all strains. A GRIM-19 overexpression vector (GRIM19 OVN) was electrophoretically injected intravenously. The levels of Th1 and Th17 cells were measured via flow cytometry, immunofluorescence, and immunohistochemical analysis. IL-17A and IFNγ expression levels were assessed via ELISA and quantitative PCR. IL-17A expression decreased and IFNγ expression increased in EAE mice that received injections of the GRIM19 OVN. GRIM-19 transgenic mice expressed more IFNγ than did wild-type mice; this inhibited EAE development. However, the effect of GRIM-19 overexpression on the EAE of IFNγ-KO mice did not differ from that of the empty vector. GRIM-19 expression was therapeutic for EAE mice, elevating the IFNγ level. GRIM-19 regulated the Th17/Treg cell balance.
참고문헌 (58)
- Huang G, "GRIM-19, a cell death regulatory protein, is essential for assembly and function of mitochondrial complex I", Mol Cell Biol, 24, pp.8447~8456 (2004)
- Tian B, "Curcumin inhibits urothelial tumor development by suppressing IGF2 and IGF2-mediated PI3K", AKT, J Drug Target, pp.2017, 25[DOI]
- Lufei C, "GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction", EMBO J, 22, pp.1325~1335 (2003)
- Zhang J, "The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3", Proc Natl Acad Sci U S A, 100, pp.9342~9347 (2003)
- Kalvakolanu DV, "Cytokine-induced tumor suppressors : a GRIM story", Cytokine, 52, pp.128~142 (2010)
- Kong D, "Overexpression of GRIM-19, a mitochondrial respiratory chain complex I protein, suppresses hepatocellular carcinoma growth", Int J Clin Exp Pathol, 7, pp.7497~7507 (2014)
- Nallar SC, "Grim-19 : A double-edged sword that regulates anti-tumor and innate immune responses", Transl Oncogenomics, 3, pp.67~79 (2008)
- Chen W, "Overexpression of GRIM-19 accelerates radiation-induced osteosarcoma cells apoptosis by p53 stabilization", Life Sci, 208, pp.232~238 (2018)
- Li F, "Downregulation of GRIM-19 is associated with hyperactivation of p-STAT3 in hepatocellular carcinoma", Med Oncol, 29, pp.3046~3054 (2012)
- Wang T, "Gene associated with retinoid-interferon-induced mortality-19 suppresses growth of lung adenocarcinoma tumor in vitro and in vivo", Lung Cancer, 72, pp.287~293 (2011)
- Zhou Y, "GRIM-19 disrupts E6", E6AP complex to rescue p53 and induce apoptosis in cervical cancers, 2011, pp.6, e22065~
- Lin H, "Upregulation of GRIM-19 augments the sensitivity of prostate cancer cells to docetaxel by targeting Rad23b", Clin Exp Pharmacol Physiol, 47, pp.76~84 (2020)
- Chen H, "Expression of GRIM-19 in missed abortion and possible pathogenesis", Fertil Steril, 103, pp.138~146 (2015)
- Fjær S, "Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model", Neurochem Int, 83-84, pp.28~40 (2015)
- Galea I, "Relapse in multiple sclerosis", BMJ, 350, pp.h1765~ (2015)
- Lorscheider J, "Defining secondary progressive multiple sclerosis", Brain, 139, pp.2395~2405 (2016)
- Owens B, "Multiple sclerosis", Nature, 540, pp.S1~ (2016)
- Bittner S, "Myelin oligodendrocyte glycoprotein(MOG35-55)induced experimental autoimmune encephalomyelitis(EAE)in C57BL", 6 mice, 2014, 51275~
- Alharbi FM, "Update in vitamin D and multiple sclerosis", Neurosciences, 20, pp.329~335 (2015)
- Rolak LA, "Multiple sclerosis : it's not the disease you thought it was", Clin Med Res, 1, pp.57~60 (2003)
- Faguy K, "Multiple sclerosis : an update", Radiol Technol, 87, pp.529~550 (2016)
- Garg N, "An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis", Brain Behav, 5, pp.e00362~ (2015)
- Yadav SK, "Advances in the immunopathogenesis of multiple sclerosis", Curr Opin Neurol, 28, pp.206~219 (2015)
- Darlington PJ, "Reciprocal Th1 and Th17 regulation by mesenchymal stem cells : implication for multiple sclerosis", Ann Neurol, 68, pp.540~545 (2010)
- Quiñones-Aguilar S, "Progressive multifocal leukoencephalopathy associated to treatment with natalizumab in Mexican patient multiple sclerosis. Case report, analysis and update", Neuroendocrinol Lett, 40, pp.222~226 (2019)
- Procaccini C, "Animal models of multiple sclerosis", Eur J Pharmacol, 759, pp.182~191 (2015)
- Kuerten S, "Fundamental differences in the dynamics of CNS lesion development and composition in MP4-and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis", Clin Immunol, 129, pp.256~267 (2008)
- Linker RA, "Models of autoimmune demyelination in the central nervous system : on the way to translational medicine", Exp Transl Stroke Med, 1, pp.5~ (2009)
- Bowles AC, "Mesenchymal stem cell-based therapy in a mouse model of experimental autoimmune encephalomyelitis(EAE)", Methods Mol Biol, 1213, pp.303~319 (2014)
- Aranami T, "Th17 Cells and autoimmune encephalomyelitis(EAE", MS), 2008, pp.57, 115~120
- Baker D, "Mouse models of multiple sclerosis : lost in translation", Curr Pharm Des, 21, pp.2440~2452 (2015)
- Pettinelli CB, "Adoptive transfer of experimental allergic encephalomyelitis in SJL", J mice after in vitro activation of lymph node cells by myelin basic protein : requirement for Lyt 1+ 2-T lymphocytes, 1981, pp.127, 1420~1423
- Ando DG, "Encephalitogenic T cells in the B10. PL model of experimental allergic encephalomyelitis(EAE)are of the Th-1 lymphokine subtype", Cell Immunol, 124, pp.132~143 (1989)
- Hofstetter HH, "Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis", Cell Immunol, 237, pp.123~130 (2005)
- Ponomarev ED, "GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis", J Immunol, 178, pp.39~48 (2007)
- El-Behi M, "The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF", Nat Immunol, 12, pp.568~575 (2011)
- Cummings M, "Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis", PLoS One, 13, pp.e0200752~ (2018)
- Giacoppo S, "Target regulation of PI3K", Akt, Fitoterapia, pp.2017, 116[DOI]
- Hamana A, "Amelioration of experimental autoimmune encephalomyelitis in mice by interferon-beta gene therapy, using a long-term expression plasmid vector", Mol Pharm, 14, pp.1212~1217 (2017)
- Hou H, "Rapamycin ameliorates experimental autoimmune encephalomyelitis by suppressing the mTOR-STAT3 pathway", Neurochem Res, 42, pp.2831~2840 (2017)
- Suda T, "Hydrodynamic gene delivery : its principles and applications", Mol Ther, 15, pp.2063~2069 (2007)
- Angell JE, "Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-β and retinoic acid combination, using a genetic approach", J Biol Chem, 275, pp.33416~33426 (2000)
- Lu H, "GRIM-19 is essential for maintenance of mitochondrial membrane potential", Mol Biol Cell, 19, pp.1893~1902 (2008)
- Yamamoto-Furusho JK, "MDP-NOD2 stimulation induces HNP-1 secretion, which contributes to NOD2 antibacterial function", Inflamm Bowel Dis, 16, pp.736~742 (2010)
- Strober W, "Signalling pathways and molecular interactions of NOD1 and NOD2", Nat Rev Immunol, 6, pp.9~20 (2006)
- Moon YM, "Gene associated with retinoid-interferon-induced mortality 19 attenuates murine autoimmune arthritis by regulation of Th17 and Treg cells", Arthritis Rheumatol, 66, pp.569~578 (2014)
- Kim JK, "Grim19 attenuates DSS induced colitis in an animal model", PLoS One, 11, pp.e0155853~ (2016)
- Park MJ, "GRIM19 ameliorates acute graft-versus-host disease(GVHD)by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation", J Transl Med, 14, pp.206~ (2016)
- Lee J, "Interferon gamma suppresses collagen-induced arthritis by regulation of Th17 through the induction of indoleamine-2, 3-deoxygenase", PLoS One, 8, pp.e60900~ (2013)
- Lee SH, "Interferon-gamma regulates inflammatory cell death by targeting necroptosis in experimental autoimmune arthritis", Sci Rep, 7, pp.10133~ (2017)
- Arellano G, "Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis", Front Immunol, 6, pp.492~ (2015)
- Miller NM, "Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis", Front Neurosci, 9, pp.287~ (2015)
- Sosa RA, "IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation", Proc Natl Acad Sci U S A, 112, pp.E5038~ (2015)
- Naves R, "The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis", J Immunol, 191, pp.2967~2977 (2013)
- Kalakonda S, "Monoallelic loss of tumor suppressor GRIM-19 promotes tumorigenesis in mice", Proc Natl Acad Sci U S A, 110, pp.E4213~ (2013)
- Kalakonda S, "Tumor suppressive protein gene associated with retinoid-interferon-induced mortality(GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels", Am J Pathol, 171, pp.1352~1368 (2007)
- Nallar SC, "GRIM-19 : a master regulator of cytokine induced tumor suppression, metastasis and energy metabolism", Cytokine Growth Factor Rev, 33, pp.1~18 (2017)
- Song J, "Grim-19 expressed by recombinant adenovirus for esophageal neoplasm target therapy", Mol Med Rep, 17, pp.6667~6674 (2018)